Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Abiomed, Inc.
  6. Notizie
  7. Altre lingue
    ABMD   US0036541003

ABIOMED, INC.

(ABMD)
Tempo differito Nasdaq  -  22:00:00 21/12/2022
381.02 USD   +0.06%
2022ABIOMED, Inc. annuncia cambiamenti nella gestione
CI
2022ABIOMED, Inc. annuncia il licenziamento di Michael R. Minogue come Amministratore Delegato
CI
2022Johnson & Johnson conclude l'acquisizione di Abiomed
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su ABIOMED, INC.
2022J&J : finalise l'acquisition d'Abiomed
2022Abiomed Inc: Completion of Acquisition or Disposition of Assets, Notice of Delisting or F..
2022ABIOMED, Inc. Announces Termination of Todd A. Trapp as Chief Financial Officer
2022ABIOMED, Inc. Announces Management Changes
2022ABIOMED, Inc. Announces Termination of Michael R. Minogue as Chief Executive Officer
2022Johnson & Johnson Closes Acquisition of Abiomed
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global BMI Index
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P TMI Index
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Equal Weighted
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Growth
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Composite 1500
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Health Care Equ..
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Healthcare Equipmen..
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P Global 1200
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from S&P 500 Ex-Financials, ..
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from NASDAQ Composite Index
2022Johnson & Johnson (NYSE:JNJ) completed the acquisition of Abiome..
2022La FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés d..
2022Impella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevan..
2022Abiomed Says US FDA Approves Impella ECP Pivotal Heart Pump
2022FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clin..
2022Abiomed Announces United States Food and Drug Administration Approves Version of Impell..
2022Steel Dynamics to Join S&P 500; Super Micro Computer to be Added to S&P MidCap 400
2022Bolsa de Madrid: Japónimación
2022Japanimation
2022En Direct des Marchés : Orange, Engie, Vinci, Elior, Derichebourg,..
2022J&J : prolongation de l'offre sur les actions Abiomed
2022Johnson & Johnson Extends Abiomed Tender Offer to Dec. 21
2022Abiomed, Inc.(NasdaqGS:ABMD) dropped from FTSE All-World Index
2022Amgen est en négociations avancées pour la reprise de Horizon - sources
2022Abiomed - First Patients in the World Treated with Impella RP Flex with SmartAssist
2022Erste Patienten weltweit mit Impella RP Flex mit SmartAssist behandelt
2022Premiers patients au monde traités par Impella RP Flex avec SmartAssist
2022First Patients in the World Treated with Impella RP Flex with SmartAssist
2022Abiomed, Inc. Announces First Patients in the World Treated with Impella Rp Flex with S..
2022Horizon Therapeutics en discussions avec plusieurs groupes dont Sanofi sur une offre
2022Horizon Therapeutics fields buyout interest from Amgen, J&J and Sanofi
2022Insider Sell: Abiomed
2022Abiomed Investor Alert By The Former: Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
2022Insider Sell: Abiomed
2022Insider Sell: Abiomed
2022Insider Sell: Abiomed
2022Abiomed Inc: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF O..
2022Tranche Update on Abiomed, Inc.'s Equity Buyback Plan announced on August 1, 2019.
2022Tranche Update on Abiomed, Inc.'s Equity Buyback Plan announced on August 4, 2022.
2022Fed Day: The suspense is killing investors
2022Abiomed Announces Second Quarter Revenue of $266 Million up 11% in Constant Currency up..
2022Analyst recommendations: BAT, Microsoft, NXP Semi, Snowflake, Cl..
2022North American Morning Briefing: Caution to -2-
2022News Highlights: Top Company News of the Day
2022Abiomed Investor Alert By The Former: Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
2022Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup
2022US Stocks Close Lower Tuesday Ahead of Fed Decision
2022US Stocks Close Lower Tuesday as Key Fed Decision Looms
2022Sector Update: Health Care Stocks Little Change Near Tuesday Close
2022Trending : Johnson & Johnson to Buy Abiomed
2022Top Midday Gainers
2022US Stocks Fall Midday After Job Opening Data
2022Sector Update: Health Care Stocks Slipping Tuesday
2022Johnson & Johnson neemt Abiomed over
2022Dpa-AFX-Überblick: UNTERNEHMEN vom 01.11.2022 - 15.15 Uhr
2022J&J to buy cardio technology company Abiomed for $16.6B
2022L'espoir d'un ralentissement des hausses de taux de la Fed soutient Wall Street
2022Johnson & Johnson Strikes $16.6 Billion Deal to Buy Heart-Device Maker Abiomed
2022J&J to buy heart pump maker Abiomed for $16.6B
2022Abiomed Posts Higher Fiscal Q2 Adjusted Earnings, Revenue
2022Sector Update: Health Care Stocks Gain Pre-Bell Tuesday
2022Johnson & Johnson achète Abiomed, valorisé 16,6 milliards
2022Sector Update: Health Care
2022Abiomed - Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart F..
2022Wall Street eyes higher open with Fed in focus
2022Aktien New York Ausblick: Gewinne - Gerüchte über Ende von Null..
2022WDH: Johnson & Johnson will Herzpumpenhersteller Abiomed kaufen
2022US Futures Higher as Markets Look to Extend October Rally
2022Abiomed Inc: Entry into a Material Definitive Agreement, Change in Directors or Principal..
2022Stocks Set to Begin November on Upbeat Tone as US Futures Rise; Europe, Asia Gain
2022Top Premarket Gainers
2022USA-Les valeurs à suivre à Wall Street (actualisé)
2022Abiomed: Fiscal Q2 Earnings Snapshot
2022Earnings Flash (ABMD) ABIOMED Reports Q2 Revenue $265.9M, vs. Street Est of $272.8M
2022Earnings Flash (ABMD) ABIOMED Posts Q2 EPS $1.30, vs. Street Est of $1.03
2022Johnson & Johnson : accord pour acquérir Abiomed
2022Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*,..
2022Abiomed, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended Sept..
2022Johnson & Johnson to Buy Abiomed For $380 per Share
2022J&J to buy Abiomed in $16.6 billion deal
2022Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement..
2022Impella RP Flex mit SmartAssist erhält FDA-Zulassung für die Behandlung von Rechtsherzi..
2022Abiomed Gets FDA Nod for Impella RP Flex with SmartAssist to Treat Right Heart Failure
2022Impella RP Flex avec SmartAssist reçoit une approbation de la FDA pour traiter l'insuff..
2022Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
2022Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure
2022 Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare
2022MedTechVets Appoints Patrice Sutherland, Enterprise Executive Director at Integra LifeS..
2022Abiomed schließt alle nach der Zulassung durchgeführten Impella-Studien in den Bereiche..
2022Abiomed termine avec succès toutes les études post approbation d'Impella pour l'ICP à h..